Recommendations for Prevention and Control of Influenza in Children, 2023-2024
Copyright © 2023 by the American Academy of Pediatrics..
This technical report accompanies the recommendations of the American Academy of Pediatrics for the routine use of influenza vaccine and antiviral medications in the prevention and treatment of influenza in children during the 2023-2024 season. The rationale for the American Academy of Pediatrics recommendation for annual influenza vaccination of all children without medical contraindications starting at 6 months of age is provided. Influenza vaccination is an important strategy for protecting children and the broader community against influenza. This technical report summarizes recent influenza seasons, morbidity and mortality in children, vaccine effectiveness, and vaccination coverage, and provides detailed guidance on vaccine storage, administration, and implementation. The report also provides a brief background on inactivated and live-attenuated influenza vaccines, available vaccines this season, vaccination during pregnancy and breastfeeding, diagnostic testing for influenza, and antiviral medications for treatment and chemoprophylaxis. Strategies to promote vaccine uptake are emphasized.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:152 |
---|---|
Enthalten in: |
Pediatrics - 152(2023), 4 vom: 01. Okt. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
COMMITTEE ON INFECTIOUS DISEASES [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 30.09.2023 published: Print Citation Status Publisher |
---|
doi: |
10.1542/peds.2023-063773 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM361398670 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM361398670 | ||
003 | DE-627 | ||
005 | 20231226085044.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1542/peds.2023-063773 |2 doi | |
028 | 5 | 2 | |a pubmed24n1204.xml |
035 | |a (DE-627)NLM361398670 | ||
035 | |a (NLM)37641884 | ||
035 | |a (PII)e2023063773 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a COMMITTEE ON INFECTIOUS DISEASES |e verfasserin |4 aut | |
245 | 1 | 0 | |a Recommendations for Prevention and Control of Influenza in Children, 2023-2024 |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 30.09.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status Publisher | ||
520 | |a Copyright © 2023 by the American Academy of Pediatrics. | ||
520 | |a This technical report accompanies the recommendations of the American Academy of Pediatrics for the routine use of influenza vaccine and antiviral medications in the prevention and treatment of influenza in children during the 2023-2024 season. The rationale for the American Academy of Pediatrics recommendation for annual influenza vaccination of all children without medical contraindications starting at 6 months of age is provided. Influenza vaccination is an important strategy for protecting children and the broader community against influenza. This technical report summarizes recent influenza seasons, morbidity and mortality in children, vaccine effectiveness, and vaccination coverage, and provides detailed guidance on vaccine storage, administration, and implementation. The report also provides a brief background on inactivated and live-attenuated influenza vaccines, available vaccines this season, vaccination during pregnancy and breastfeeding, diagnostic testing for influenza, and antiviral medications for treatment and chemoprophylaxis. Strategies to promote vaccine uptake are emphasized | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a O'Leary, Sean T |e investigator |4 oth | |
700 | 1 | |a Campbell, James D |e investigator |4 oth | |
700 | 1 | |a Ardura, Monica I |e investigator |4 oth | |
700 | 1 | |a Banerjee, Ritu |e investigator |4 oth | |
700 | 1 | |a Bryant, Kristina A |e investigator |4 oth | |
700 | 1 | |a Caserta, Mary T |e investigator |4 oth | |
700 | 1 | |a Frenck, Robert W |e investigator |4 oth | |
700 | 1 | |a Gerber, Jeffrey S |e investigator |4 oth | |
700 | 1 | |a John, Chandy C |e investigator |4 oth | |
700 | 1 | |a Kourtis, Athena P |e investigator |4 oth | |
700 | 1 | |a Myers, Angela |e investigator |4 oth | |
700 | 1 | |a Pannaraj, Pia |e investigator |4 oth | |
700 | 1 | |a Ratner, Adam J |e investigator |4 oth | |
700 | 1 | |a Shah, Samir S |e investigator |4 oth | |
700 | 1 | |a Bryant, Kristina A |e investigator |4 oth | |
700 | 1 | |a Hofstetter, Annika M |e investigator |4 oth | |
700 | 1 | |a Chaparro, Juan D |e investigator |4 oth | |
700 | 1 | |a Michel, Jeremy J |e investigator |4 oth | |
700 | 1 | |a Kimberlin, David W |e investigator |4 oth | |
700 | 1 | |a Barnett, Elizabeth D |e investigator |4 oth | |
700 | 1 | |a Lynfield, Ruth |e investigator |4 oth | |
700 | 1 | |a Sawyer, Mark H |e investigator |4 oth | |
700 | 1 | |a Bernstein, Henry H |e investigator |4 oth | |
700 | 1 | |a Cardemil, Cristina V |e investigator |4 oth | |
700 | 1 | |a Farizo, Karen M |e investigator |4 oth | |
700 | 1 | |a Kafer, Lisa M |e investigator |4 oth | |
700 | 1 | |a Kim, David |e investigator |4 oth | |
700 | 1 | |a López Medina, Eduardo |e investigator |4 oth | |
700 | 1 | |a Moore, Denee |e investigator |4 oth | |
700 | 1 | |a Panagiotakopoulos, Lakshmi |e investigator |4 oth | |
700 | 1 | |a Romero, José R |e investigator |4 oth | |
700 | 1 | |a Sauvé, Laura |e investigator |4 oth | |
700 | 1 | |a Starke, Jeffrey R |e investigator |4 oth | |
700 | 1 | |a Thompson, Jennifer |e investigator |4 oth | |
700 | 1 | |a Wharton, Melinda |e investigator |4 oth | |
700 | 1 | |a Woods, Charles R |e investigator |4 oth | |
700 | 1 | |a Frantz, Jennifer M |e investigator |4 oth | |
700 | 1 | |a Gibbs, Gillian |e investigator |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Pediatrics |d 1948 |g 152(2023), 4 vom: 01. Okt. |w (DE-627)NLM000021687 |x 1098-4275 |7 nnns |
773 | 1 | 8 | |g volume:152 |g year:2023 |g number:4 |g day:01 |g month:10 |
856 | 4 | 0 | |u http://dx.doi.org/10.1542/peds.2023-063773 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 152 |j 2023 |e 4 |b 01 |c 10 |